MPI Research Breaks Ground on New Imaging Center - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

MPI Research Breaks Ground on New Imaging Center



MPI Research, in partnership with INVICRO and 3D Imaging, held the groundbreaking for its new Imaging Center, which is set to open in Spring 2014 at the MPI Research corporate headquarters in Mattawan, Michigan. Pharmaceutical researchers will have access to a cyclotron facility directly connected to vivarium, permitting drug radiolabeling and in-depth studies across a variety of animal models.

The 10,000 ft2, two-story imaging center is the latest joint effort between MPI, INVICRO, and 3D Imaging, which have collaborated on more than 100 imaging projects to date. The multimillion-dollar project will include INVICRO’s molecular imaging informatics team and 3D Imaging’s radiopharmaceutical group.

Many of the expanded imaging solutions, including nonhuman primate PET and CT imaging capabilities, became available in July 2013.

Source: MPI Research

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here